Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells
about
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataPhysicochemical and biological characterization of 1E10 anti-idiotype vaccine.Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive SystemMolecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.Cancer vaccines and carbohydrate epitopes.Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences.Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma.Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine.Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.Racotumomab for treating lung cancer and pediatric refractory malignancies.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties.N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese.Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.Detection of Naturally Occurring Human Antibodies Against Gangliosides by ELISA.Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.Connecting immunology research to public health: Cuban biotechnology.Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3.Update on immune checkpoint inhibitors in lung cancer
P2860
Q30575331-8A96CBCA-FD3D-4371-95B4-349F5200421DQ34080417-D00A1E00-1FFA-49BF-B5AA-2D0C5CA8C42DQ34449304-1F2485DB-DA8B-48D0-B634-3246A8DB056FQ35200716-2D31D300-693A-4B29-8A3B-DE2D1BB904ACQ35217621-009A57B0-2CA5-4A4F-9508-70D90334D1BCQ35525289-555B0107-EEAB-4E82-AA44-2599BDD810B4Q35623519-24A734D6-DEC6-44EC-8736-40486D6174E3Q35854131-87AB2C16-AB42-4E4D-A931-103E923EA8BEQ36304631-C2B40F9C-C0C6-47BA-84B8-F7FD241E5FB4Q36307886-3197F472-F3C4-4EE1-977E-C78D3DAC1617Q36410563-06ABCC2B-2F30-495D-893C-2A72109FE289Q36978403-6B802AFB-8FFA-4C7E-97FC-4BC80A33EE4FQ37594945-B671C56E-6FF8-4C59-9CBD-A2AED2D2CB9FQ37974938-7A66A366-A145-429E-99C0-C19C75A571ABQ38207923-29DDAA98-A048-4051-8161-73D9BD95B651Q38285397-0751B535-1CCF-4A0E-ABDF-3983E2AE9A27Q38745411-A7DE04BC-E430-4EAA-98AD-7288CD33455AQ38848896-E39A2F0B-7E77-4EB4-A350-C23BD4B7298FQ39172701-983DB8C6-6900-49C2-8F91-37545F0DB82CQ39210534-2445B7AA-97BC-468D-87DC-8C3C9D7608ADQ39350862-C4893E8A-078F-4FA4-8EEA-9FE537F04CE0Q39750020-DA968E1D-A571-4912-BB79-35FC4F6381E8Q40151254-D117716D-EAE7-4CED-B2C0-3BC5AA5F60A3Q40729252-D833E815-30AA-4E17-8A4C-83303E5A5D8CQ42560665-D082F6F0-D178-47AE-BC02-60B56F419D08Q46801745-F5202908-6D0F-4662-98E5-B8206B19C1DCQ55439726-C0829C82-E4E6-4A23-9F91-E730F13F2C51Q56897146-7C7E65DA-E170-408C-9AD6-C1C3A46581FB
P2860
Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells
description
im Oktober 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2005
@uk
name
Role of tumour-associated N-gl ...... over CD4 expression on T cells
@en
Role of tumour-associated N-gl ...... over CD4 expression on T cells
@nl
type
label
Role of tumour-associated N-gl ...... over CD4 expression on T cells
@en
Role of tumour-associated N-gl ...... over CD4 expression on T cells
@nl
prefLabel
Role of tumour-associated N-gl ...... over CD4 expression on T cells
@en
Role of tumour-associated N-gl ...... over CD4 expression on T cells
@nl
P2093
P2860
P1476
Role of tumour-associated N-gl ...... over CD4 expression on T cells
@en
P2093
Audry Fernández
Circe Mesa
Joel de Leòn
Luis E. Fernández
Marilyn Clavel
P2860
P2888
P304
P356
10.1007/S00262-005-0041-6
P577
2005-10-06T00:00:00Z